New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.

Ni, W

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. [electronic resource] - Circulation Apr 2001 - 2096-101 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0009-7322

10.1161/01.cir.103.16.2096 doi


Animals
Aorta--drug effects
Apolipoproteins E--deficiency
Arteriosclerosis--genetics
Chemokine CCL2--antagonists & inhibitors
Chemotaxis--drug effects
Disease Models, Animal
Disease Progression
Genetic Therapy--methods
Humans
Leukocyte Count
Lipids--blood
Mice
Mice, Inbred C57BL
Mice, Knockout
Monocytes--cytology
Muscle, Skeletal--drug effects
Peptide Fragments--genetics
Recombinant Proteins--pharmacology
Sequence Deletion
Skin--cytology
Transfection
Treatment Outcome